NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
TerminatedPhase 2
Sponsor: Pfizer
Conditions: Alopecia Areata
Interventions: PF-06651600, Placebo
Countries: United States, Australia, Canada, Poland
This is a global Phase 2a randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of ritlecitinib in adults aged 18 to ≤50 years of age with ≥25% scalp hair loss due to Alopecia Areata (AA).
Eligibility overview
Sex: ALL
Age: 18 Years to 50 Years
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * Diagnosis of alopecia areata, including alopecia totalis and alopecia universalis. * At least 25% hair loss due to alopecia areata * Must have normal hearing and normal brainstem auditory evoked potentials (BAEPs) * Must have a normal neurological exam; can have a stable unilateral median neuropathy or ulnar neuropathy * Signed informed consent * Stable regimen for other medications before and during the study Exclusion Criteria: * Other significant medical conditions * Occupational or recreational noise exposure * History of peripheral neuropathy or first degree relative with a hereditary peripheral neuropathy * HbA1c \> or = 7.5% at Screening * Recurrent or disseminated Herpes Zoster * Active or chronic infection; or infection requiring hospitalization or IV antimicrobials within 6 months * Active or latent (insufficiently treated) Hepatitis * Active or latent (insufficiently treated) TB * Concomitant medications associated with peripheral neurologic or hearing loss * Protocol specific laboratory abnormalities
Locations (38)
- Huntington Beach, California, United States
- Irvine, California, United States
- Boca Raton, Florida, United States
- Hollywood, Florida, United States
- Jacksonville, Florida, United States
- Jacksonville, Florida, United States
- Miami, Florida, United States
- Miramar, Florida, United States
- Orlando, Florida, United States
- Oviedo, Florida, United States
- Tampa, Florida, United States
- Skokie, Illinois, United States
- Skokie, Illinois, United States
- St Louis, Missouri, United States
- Albuquerque, New Mexico, United States
- Albuquerque, New Mexico, United States
- Stony Brook, New York, United States
- Raleigh, North Carolina, United States
- Austin, Texas, United States
- Houston, Texas, United States
- Franklin, Virginia, United States
- Lynchburg, Virginia, United States
- Norfolk, Virginia, United States
- Kogarah, New South Wales, Australia
- Box Hill, Victoria, Australia
- East Melbourne, Victoria, Australia
- Markham, Ontario, Canada
- Peterborough, Ontario, Canada
- Verdun, Quebec, Canada
- Québec, Canada
- + 8 more on CT.gov